Electrotherapy Devices (TENS, EMS) in New Jersey

ADM Tronics Unlimited, Inc. is a full-service electronic medical device innovation firm specializing in design, engineering, development, and manufacturing of diagnostic and therapeutic medical technologies. The company operates an FDA-regulated facility with robust quality control and manufacturing capabilities, bringing medical devices from concept through production. ADMT maintains extensive regulatory expertise across FDA, GMP, CE, ISO 13485, CMDCAS, ETL, and UL standards. The company has developed proprietary non-invasive electrotherapy medical devices spanning multiple therapeutic areas including audiology, physical medicine, wound therapy, neurology, and urology. Key proprietary products include Aurex (tinnitus treatment), Sonotron (non-invasive RF electrotherapy for pain management), and Vet-Sonotron (veterinary non-invasive therapy). ADMT also manufactures specialty water-based formulations and products through subsidiaries including Aqua Based Technologies (primers, adhesives, coatings), Antistatic Industries (static-safe materials and StaticPaint®), and Pros-Aide® (medical prosthetic and special effects adhesive). The company is publicly traded on the OTCQB marketplace under symbol ADMT and has a multi-generational heritage of innovation in electronics and electromechanical design.

Lympha Press USA manufactures pneumatic compression therapy systems and garments for at-home management of lymphedema, chronic venous insufficiency, and lipedema. The company's primary product line includes the Optimal Plus™ digitally-connected compression pump system, which delivers clinically proven sequential compression therapy with flexible, condition-tailored settings. Product offerings encompass compression pumps, lower body garments (Lympha Pants), upper body garments (Lympha Jacket), and the LymphaPod® portable compression device. The company emphasizes patient compliance and ease of use, reporting high user satisfaction and sustained treatment adherence rates. Lympha Press targets both individual patients seeking home-based therapy and clinicians managing patient care. The platform integrates digital connectivity to support remote monitoring and therapy adjustments. All products are designed for long-term home use and daily wear. The company maintains a patient education community and clinician support resources to optimize outcomes for chronic lymphatic and venous conditions affecting approximately 10 million Americans.

Alikai Health is a specialized durable medical equipment (DME) distributor founded in 2013, focused on non-invasive rehabilitation and therapy solutions for injured workers and chronic pain patients. The company serves doctors, patients, and insurance carriers with a curated portfolio of rehabilitation equipment designed to reduce opioid and NSAID dependency. Core product categories include electrotherapy devices (TENS, EMS), cryotherapy, thermotherapy, spinal bracing, and upper/lower extremity bracing. Alikai is the exclusive U.S. distributor of InfraRx™, a prescription-only infrared therapeutic system clinically proven to reduce pain by more than 50%, marketed for home use in treating whiplash, sprains, strains, arthritis, and degenerative disc disease. The company partners with leading manufacturers including DJO, Aspen, and DeRoyal. Alikai maintains in-network relationships with most major DME Third Party Administrators and manages billing for worker's compensation and insurance claims. The company positions itself as a clinical outcomes partner, emphasizing evidence-based product selection and patient education through how-to pamphlets and customer support. The business model targets occupational health, orthopedic, and chiropractic practices seeking alternatives to pharmaceutical interventions for musculoskeletal and pain conditions.

electroCore is a bioelectronic medicine company specializing in non-invasive vagus nerve stimulation (nVNS) technology. The company develops and commercializes proprietary nVNS devices designed to treat various neurological and immunological disorders. Their flagship product, gammaCore, is a wearable nVNS device that stimulates the vagus nerve to deliver therapeutic benefits for conditions including migraine, cluster headache, PTSD, and mild traumatic brain injury. The company has published clinical evidence in peer-reviewed journals demonstrating the efficacy of nVNS therapy across multiple indications. electroCore positions itself as a pioneer in bioelectronic medicine, leveraging vagus nerve stimulation as a drug-free, non-invasive therapeutic approach. The company is publicly traded on NASDAQ and actively pursues investigator-led clinical trials to expand the therapeutic applications of their nVNS platform. Their products are designed for patient self-administration and home use, making them accessible to broader patient populations.

JOGO Health is a digital therapeutics company specializing in FDA-registered Class II EMG biofeedback systems for pain and neuromuscular disorder management. The platform integrates wearable sensors with advanced AI to leverage neuroplasticity, delivering non-invasive, medication-free virtual rehabilitation. Founded on research by Dr. Joseph Brudny (NYU) and Dr. Gordon Silverman (Rockefeller University), JOGO combines Electromyography biofeedback, Pain Neuroscience Education, Pain Reprocessing Therapy, and physical therapy. Clinical trials at Brigham and Women's Hospital (Harvard) and Mayo Clinic demonstrated superior outcomes versus opioids for chronic pain and superiority over standard care for neuromuscular disorders. The platform enables hybrid or fully virtual tele-rehabilitation, allowing home-based therapy. Medicare and major commercial payers cover JOGO for migraine, tension-type headache, cancer pain, urinary incontinence, pelvic pain, fecal incontinence, chronic constipation, stroke recovery, and neurorehabilitation. Indicated conditions include Parkinson's, Essential Tremor, cerebral palsy, Bell's palsy, spinal cord injury, and multiple sclerosis.

Soterix Medical is the global leader in non-invasive neuromodulation and integrated brain monitoring technology. The company designs, manufactures, and markets advanced research and clinical-grade systems for transcranial electrical stimulation (tDCS, tES, HD-tES), transcranial magnetic stimulation (TMS, MEGA-TMS), transcranial focused ultrasound stimulation (tFUS), and related modalities. Research platforms include 1x1 tDCS/tES systems, high-definition HD-tES platforms, temporal interference stimulation (TI), taVNS (transcutaneous auricular vagus nerve stimulation), galvanic vestibular stimulation, and fully integrated multimodal solutions combining stimulation with EEG, fMRI, PET, and fNIRS. Clinical systems target depression (tDCS-LTE), pain conditions (PainX tDCS and TENS), and major depressive disorder (SPRY TMS). The company also offers neurotargeting software (HD-Explore, HD-Targets, tDCS-Explore), mobile EEG systems, and animal pre-clinical stimulation systems. Soterix holds FDA 510(k) clearances for multiple products including Depression tDCS-LTE, SPRY TMS, IontoDC, MEGA-IOM intraoperative neuromonitoring, and Neural Navigator TMS neuronavigation. CE Mark approvals exist for 1x1 tDCS depression and PainX pain treatment. The company serves academic research centers, clinical institutions, and specialized neurology and psychiatry practices worldwide. Manufacturing and quality standards reflect commitment to precision, usability, and regulatory compliance across research and clinical applications.

NeuroMetrix, Inc. is a neurotechnology company specializing in non-invasive medical devices for diagnosing and treating pain and neurological disorders. The company develops point-of-care neuropathy diagnostic tests and FDA-approved wearable neurostimulation devices. Its Quell® platform is a wearable neuromodulator designed for chronic pain management and fibromyalgia symptom reduction. DPNCheck provides rapid nerve conduction testing for peripheral neuropathy evaluation. NeuroMetrix targets healthcare professionals including endocrinologists and podiatrists, as well as direct consumers. Founded in 1996 and based in Woburn, Massachusetts, the company is a wholly-owned subsidiary of electroCore, Inc. and is publicly traded on Nasdaq (NURO). The company emphasizes innovation in digital medicine and neurostimulation through clinical feedback and research.